William Blair & Company’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-43,000
Closed -$160K 2032
2021
Q3
$160K Hold
43,000
﹤0.01% 1544
2021
Q2
$257K Buy
43,000
+3,000
+8% +$15.9K ﹤0.01% 1407
2021
Q1
$264K Buy
40,000
+4,000
+11% +$26.3K ﹤0.01% 1381
2020
Q4
$203K Buy
+36,000
New +$198K ﹤0.01% 1429

Other funds holding ARAV

William Blair & Company's ARAV Position: Q4 2021 in Review

William Blair & Company sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2021, closing a stake of 43,000 shares — an estimated $160K sold.

William Blair & Company first reported a position in ARAV in Q4 2020 and held it in 4 quarters. The position peaked at $264K in Q1 2021. 36 funds tracked by Wall St. Rank hold ARAV as of Q4 2021.

  • William Blair & Company reported no remaining Aravive, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • William Blair & Company sold 43,000 Aravive, Inc. Common Stock shares in Q4 2021, an estimated $160K.
  • William Blair & Company first reported a position in Aravive, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • William Blair & Company's Aravive, Inc. Common Stock position peaked at $264K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2021.

Based on William Blair & Company's 13F filing for Q4 2021, filed 14 Feb 2022.